Business Wire

OpenLink Hires Former IBM Cloud CMO Nancy Pearson as New Chief Marketing Officer

Share

OpenLink, the global leader in trading, treasury and risk management solutions for the energy, commodities, corporate and financial services industries, has appointed senior IBM executive Nancy Pearson as its new Chief Marketing Officer (CMO). Based in New York, Ms. Pearson will take responsibility for aligning OpenLink’s strategy, value proposition, and global marketing team, bringing considerable experience in cloud and cognitive solutions to the role.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170502005104/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Nancy Pearson (Photo: Business Wire)

Ms. Pearson’s recent roles have included CMO of IBM Cloud and Global Head of Marketing for IBM Cognitive (Watson), and have seen her recognized as a leader in the technology industry. In 2015, she was named as one of the top 25 most influential women in Cloud, Power 100 Most Powerful Women of the Channel, and SiliconANGLE 2015 Women Who Rocked the Tech World.

“We’re delighted to welcome Nancy to our executive team,” said John O’Malley, CEO, OpenLink. “Nancy was previously with IBM where she engaged in several entrepreneurial businesses, helping launch many early-stage strategic solutions into globally recognized brands, including IBM Cloud, Linux, Watson and others. She was responsible for Global Marketing for IBM’s leadership brands WebSphere, Tivoli, Information Management and others. Nancy is a leader in the technology industry and has been recognized as such numerous times. No one is better placed to help accelerate growth in our key markets.”

“I’m joining OpenLink at a really exciting time,” said Ms. Pearson. “In previous roles, I’ve launched new brands and initiatives within established global businesses. This position allows me to translate that experience to a new space and use it to help grow an already market-leading business. We have great plans ahead.”

Ms. Pearson holds a B.A. in psychology/human relations from Pace University, an M.S. in adult education/human resource development from Fordham University and an M.M. in market management from Columbia Business School.

About OpenLink

Founded in 1992, OpenLink (www.openlink.com) is the global leader in trading, treasury and risk management solutions for the commodity, energy, corporate and financial services industries. OpenLink's products address treasury, portfolio management, trading, risk management, and operations processing for both financial and physical assets. OpenLink has consistently received numerous industry awards and recognition, including citations as the industry leader in Commodity/Energy Trading and Risk Management (C/ETRM) systems, and first-in-class ranking by Energy Risk magazine, with analyst firms Chartis and Gartner citing OpenLink as a leader in financial platforms.

The company serves over 600 clients, including 12 of the world's largest commodity and energy companies, 9 of the largest financial institutions, and 13 of the largest central banks. OpenLink has 1,200 employees in 14 global offices on five continents, with headquarters outside New York City and field offices in Houston, Manhattan, London, Berlin, Vienna, Toronto, Tulsa, São Paulo, Mexico City, Bangalore, Singapore, Dubai and Sydney.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

OpenLink
Michael Golding
Global Head of Public Relations
michael.golding@openlink.com
Mobile: +44 (0)7766398912

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

SBC Medical added to membership of Russell 3000 ® Index28.6.2025 02:30:00 EEST | Press release

SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global franchise and provider of services for aesthetic clinics, has been added as a member of the broad-market Russell 3000® Index, effective after the US market opens on June 30, as part of the 2025 Russell indexes reconstitution. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250608244276/en/ Yoshiyuki Aikawa-Director (Chairman), CEO Membership in the Russell 3000® Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000® Index or small-cap Russell 2000®Index as well as the appropriate growth and value style indexes. Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. According to the data as of the end of June 2024, about $10.6 trillion in assets are benchmarked against the Russell US indexes, which belong to

Altimetrik and SLK Software Join Forces to Create an AI-First Engineering Services Powerhouse27.6.2025 23:44:00 EEST | Press release

Altimetrik, a pure-play AI, Data and Digital engineering solutions company, today announced the signing of a definitive agreement to acquire SLK Software (“SLK”), a global technology services firm focused on delivering AI, intelligence automation and analytics solutions. The acquisition will further strengthen Altimetrik’s end-to-end enablement services and expand its customer reach, with a clear path to accelerate towards Altimetrik’s goal of reaching $1billion in annual revenue. The transaction remains subject to customary closing conditions and is expected to close in the second half of 2025. Financial details were not disclosed. Founded in 2000, SLK is recognized as a leader in the tech industry, and for its commitment to create innovative digital solutions. This strategic acquisition will significantly enhance the scale of Altimetrik’s capabilities, bringing together Altimetrik’s AI-first, platform-native engineering model and SLK’s full technology services stack that will further

PRD Therapeutics Announces Initiation of First-in-Human Study for PRD00127.6.2025 17:00:00 EEST | Press release

PRD Therapeutics, Inc., a clinical stage company focused on the development of novel lipid metabolism regulators targeting homozygous familial hypercholesterolemia (HoFH) and metabolic dysfunction associated fatty liver disease (MASH/MASLD), today announced that the company recently initiated dosing in a First-in-Human (FIH) clinical trial of PRD001, a first-in-class SOAT2 (formerly known as ACAT2) selective inhibitor. “We are excited to initiate dosing in this clinical trial of PRD001. Many clinical trials have been conducted on SOAT1/2 dual or SOAT1 selective inhibitors, but this is the first clinical trial of an SOAT2 selective inhibitor” said Kanji Hosoda, Ph.D., CEO and co-founder of PRD Therapeutics. “Several results with SOAT1 or 2 knockout mice have been published, suggesting that knocking out or inhibiting only SOAT2 is crucial to demonstrate safety and efficacy. PRD001 is the world's first and only SOAT2-selective inhibitor and is expected to exhibit safety and efficacy in hu

STEMCELL Technologies Introduces STEMprep™ Tissue Dissociator System to Accelerate Research Discoveries27.6.2025 15:00:00 EEST | Press release

To help scientists accelerate their workflows, STEMCELL Technologies has commercially launched the STEMprep™ Tissue Dissociator System—a new benchtop instrument that automates, standardizes, and streamlines tissue dissociation, the process of breaking down tissue samples into single-cell suspensions for research purposes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250627342791/en/ To help scientists accelerate their workflows, STEMCELL Technologies has commercially launched the STEMprep™ Tissue Dissociator System—a new benchtop instrument that automates, standardizes, and streamlines tissue dissociation, the process of breaking down tissue samples into single-cell suspensions for research purposes. “Tissue dissociation is incredibly important for making advancements in research fields, like cancer and immunology, yet this manual process demands significant time and effort and can lead to inconsistent results,” said Dr. A

Pure Lithium Founder & CEO Emilie Bodoin Recognized for Trailblazing Woman of the Year at 2025 Volta Foundation Awards at 17 th Annual Fastmarkets Lithium Supply and Battery Raw Materials Conference27.6.2025 13:00:00 EEST | Press release

Pure Lithium Corporation, a disruptive vertically integrated lithium metal battery technology company, is pleased to announce that its Founder, Chairman & CEO, Emilie Bodoin received special recognition for Trailblazing Woman of the Year Award Sponsored by ExxonMobil at the 2025 Fastmarkets Volta Awards Ceremony, in Las Vegas, Nevada on June 24. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250627170164/en/ This award celebrates an exceptional female leader who has demonstrated outstanding leadership, vision, and impact within her industry. It recognizes achievements in driving innovation, fostering diversity, and inspiring others while making significant contributions to her organization. “I am truly honored to receive special recognition for this award. One of the best things about my role is the opportunity to lead by example and encourage and inspire women and girls who may not yet recognize their potential. To all of m

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye